Comparison Chart Intensity Therapeutics, Inc.
Stocks
INTS
US45828J2024
Biotechnology & Medical Research
|
Delayed
Nasdaq
16:00:00 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 3.290 USD | -1.79% |
|
-0.60% | -67.92% |
| 08-11 | Intensity Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-11 | Intensity Therapeutics, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -1.79% | -0.60% | -67.92% | -49.56% | - | 10.74M |  |  | |
- Stock Market
- Stocks
- INTS Stock
- Charts Intensity Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
